Jun 04, 2020
Taiho Oncology To Present Data on Futibatinib (TAS-120) at the AACR Annual Meeting 2020
May 30, 2020
Guardant360 test results may provide prognostic information beyond the detection of actionable biomarkers for ALK-rearranged NSCLC patients
May 29, 2020
Blueprint Medicines Announces Data Presentations at ASCO20 Highlighting Deep, Durable Clinical Activity and Well-Tolerated Safety Profile of Pralsetinib Across Broad Range of RET Fusion-Positive Tumors
May 15, 2020
Ascentage Pharma to Present Six Abstracts at 2020 AACR Annual Meeting
May 06, 2020
Novartis announces FDA approval of MET inhibitor Tabrecta(TM) for metastatic non-small cell lung cancer with METex14
Apr 22, 2020
CStone announces acceptance of its first New Drug Application in mainland China by the National Medical Products Administration, for the first-in-class precision therapy avapritinib in two gastrointestinal stromal tumor indications
Apr 19, 2020
Innovent Biologics Announces FDA Approval of Pemazyre(TM) (Pemigatinib) as First Targeted Treatment for Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma
Feb 10, 2020
Kanazawa University Research: Combined Drug Treatment for Lung Cancer and Secondary Tumors
Jan 21, 2020
LUNGevity and the ALK Positive Group Partner to Fund $1 Million in Lung Cancer Research Awards
Jan 17, 2020
PANTHERx® Rare Pharmacy Selected by Blueprint Medicines Corporation to Distribute AYVAKIT(TM) (avapritinib) for Genomically Defined Patient Population with Rare Cancer, GIST
Jan 13, 2020
Blueprint Medicines Announces 2020 Corporate Goals
Jan 07, 2020
Hummingbird Bioscience Publishes Preclinical Data Demonstrating Efficacy of HMBD-001 in HER3 Driven Cancers
Dec 30, 2019
Lilly Opens Phase 3 Clinical Trial in RET-Mutant Medullary Thyroid Cancer
Dec 11, 2019
Lilly Opens First Ever Randomized Phase 3 Clinical Trial in Treatment-Naïve RET Fusion-Positive Non-Small Cell Lung Cancer
Dec 09, 2019
BerGenBio Presents Preliminary Clinical Data From Phase II Combination Trial of Bemcentinib and LDAC in Elderly AML Patients at ASH 2019
Nov 21, 2019
Biocept Announces the Launch of its Liquid Biopsy Test to Detect TRK Biomarkers in the Blood of Patients Diagnosed with Cancer
Nov 19, 2019
BerGenBio ASA: Results for the Third Quarter 2019
Nov 12, 2019
Clinical investigation for use of targeted chemotherapy for esophageal cancer
Nov 11, 2019
NuProbe Launches Ultrasensitive Sanger Assays for Oncology Therapy Selection and Recurrence Monitoring
Nov 08, 2019
BerGenBio Presents Updated Phase 2 NSCLC Clinical and Translational Data for Bemcentinib in Combination With KEYTRUDA®